Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Findings of Multiple Myeloma in Afro-Caribbean Patients in the United States.

Banavali A, Neculiseanu E, Draksharam PL, Datla S, Savjani M, Park J, Sidhu G, Taiwo EO.

J Glob Oncol. 2018 Sep;(4):1-6. doi: 10.1200/JGO.17.00133.

PMID:
30241239
2.

Poldip2 knockdown inhibits vascular smooth muscle proliferation and neointima formation by regulating the expression of PCNA and p21.

Datla SR, L Hilenski L, Seidel-Rogol B, Dikalova AE, Harousseau M, Punkova L, Joseph G, Taylor WR, Lassègue B, Griendling KK.

Lab Invest. 2018 Sep 20. doi: 10.1038/s41374-018-0103-y. [Epub ahead of print]

PMID:
30237457
3.

Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain?

Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Datla S, Dirksen CD, Johnson MJ, van Kuijk SMJ, Wouters EFM, Janssen DJA.

Eur Respir J. 2018 Jul 19;52(1). pii: 1800882. doi: 10.1183/13993003.00882-2018. Print 2018 Jul. No abstract available.

PMID:
30026306
4.

Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis.

Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Datla S, Dirksen CD, Johnson MJ, van Kuijk SMJ, Wouters EFM, Janssen DJA.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701153. doi: 10.1183/13993003.01153-2017. Print 2017 Nov. Review.

PMID:
29167300
5.

Synthesis and biological assessment of 3,7-dihydroxytropolones.

Hirsch DR, Schiavone DV, Berkowitz AJ, Morrison LA, Masaoka T, Wilson JA, Lomonosova E, Zhao H, Patel BS, Datla SH, Hoft SG, Majidi SJ, Pal RK, Gallicchio E, Tang L, Tavis JE, Le Grice SFJ, Beutler JA, Murelli RP.

Org Biomol Chem. 2017 Dec 19;16(1):62-69. doi: 10.1039/c7ob02453c.

PMID:
29098212
6.

Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.

Minaya MA, Jensen TL, Goll JB, Korom M, Datla SH, Belshe RB, Morrison LA.

J Virol. 2017 Nov 14;91(23). pii: e00942-17. doi: 10.1128/JVI.00942-17. Print 2017 Dec 1.

7.

A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells.

Sharma S, Mishra R, Bigham GE, Wehman B, Khan MM, Xu H, Saha P, Goo YA, Datla SR, Chen L, Tulapurkar ME, Taylor BS, Yang P, Karathanasis S, Goodlett DR, Kaushal S.

Circ Res. 2017 Mar 3;120(5):816-834. doi: 10.1161/CIRCRESAHA.116.309782. Epub 2016 Dec 1.

8.

Pediatric End-Stage Failing Hearts Demonstrate Increased Cardiac Stem Cells.

Wehman B, Sharma S, Mishra R, Guo Y, Colletti EJ, Kon ZN, Datla SR, Siddiqui OT, Balachandran K, Kaushal S.

Ann Thorac Surg. 2015 Aug;100(2):615-22. doi: 10.1016/j.athoracsur.2015.04.088. Epub 2015 Jun 30.

9.

Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretome.

Sharma S, Mishra R, Simpson D, Wehman B, Colletti EJ, Deshmukh S, Datla SR, Balachandran K, Guo Y, Chen L, Siddiqui OT, Kaushal S, Kaushal S.

Stem Cells. 2015 Apr;33(4):1213-29. doi: 10.1002/stem.1937.

10.

Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization.

Datla SR, McGrail DJ, Vukelic S, Huff LP, Lyle AN, Pounkova L, Lee M, Seidel-Rogol B, Khalil MK, Hilenski LL, Terada LS, Dawson MR, Lassègue B, Griendling KK.

Am J Physiol Heart Circ Physiol. 2014 Oct 1;307(7):H945-57. doi: 10.1152/ajpheart.00918.2013. Epub 2014 Jul 25.

11.

Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.

Bhargava A, Hayakawa K, Silverman E, Haider S, Alluri KC, Datla S, Diviti S, Kuchipudi V, Muppavarapu KS, Lephart PR, Marchaim D, Kaye KS.

Infect Control Hosp Epidemiol. 2014 Apr;35(4):398-405. doi: 10.1086/675614.

PMID:
24602945
12.

Polymerase delta interacting protein 2 sustains vascular structure and function.

Sutliff RL, Hilenski LL, Amanso AM, Parastatidis I, Dikalova AE, Hansen L, Datla SR, Long JS, El-Ali AM, Joseph G, Gleason RL Jr, Taylor WR, Hart CM, Griendling KK, Lassègue B.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2154-61. doi: 10.1161/ATVBAHA.113.301913. Epub 2013 Jul 3. Erratum in: Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):e132.

13.

Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.

Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS.

Antimicrob Agents Chemother. 2013 Aug;57(8):4010-8. doi: 10.1128/AAC.02516-12. Epub 2013 Jun 10.

14.

Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells.

Williams HC, San Martín A, Adamo CM, Seidel-Rogol B, Pounkova L, Datla SR, Lassègue B, Bear JE, Griendling K.

Circ Res. 2012 Jun 22;111(1):56-65. doi: 10.1161/CIRCRESAHA.111.255745. Epub 2012 May 22.

15.

Reactive oxygen species, NADPH oxidases, and hypertension.

Datla SR, Griendling KK.

Hypertension. 2010 Sep;56(3):325-30. doi: 10.1161/HYPERTENSIONAHA.109.142422. Epub 2010 Jul 19. No abstract available.

16.

Prevention of aortic elastic lamina defects by losartan in apolipoprotein(E)-deficient mouse.

Chan EC, Jones GT, Dusting GJ, Datla SR, Jiang F.

Clin Exp Pharmacol Physiol. 2009 Sep;36(9):919-24. doi: 10.1111/j.1440-1681.2009.05169.x. Epub 2009 Mar 2.

PMID:
19298535
17.

Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation.

Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, Lassègue B, Griendling KK.

Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):480-7. doi: 10.1161/ATVBAHA.108.181925. Epub 2009 Jan 15.

18.

Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro.

Datla SR, Peshavariya H, Dusting GJ, Mahadev K, Goldstein BJ, Jiang F.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2319-24. Epub 2007 Aug 23.

PMID:
17717289
19.

Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress.

Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F.

Hypertension. 2007 Oct;50(4):636-42. Epub 2007 Aug 6.

PMID:
17679649
20.

Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.

Chan EC, Datla SR, Dilley R, Hickey H, Drummond GR, Dusting GJ.

Cardiovasc Res. 2007 Sep 1;75(4):710-8. Epub 2007 Jun 19.

PMID:
17659266
21.

NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells.

Jiang F, Roberts SJ, Datla Sr, Dusting GJ.

Hypertension. 2006 Nov;48(5):950-7. Epub 2006 Sep 18.

PMID:
16982957
22.

Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration.

Singh SK, Vobbalareddy S, Kalleda SR, Casturi SR, Datla SR, Mamidi RN, Mullangi R, Ramanujam R, Yeleswarapu KR, Iqbal J.

Bioorg Med Chem. 2006 Dec 15;14(24):8626-34. Epub 2006 Sep 1.

PMID:
16949828
23.

Antihypertensive effect of ragaglitazar: a novel PPARalpha and gamma dual activator.

Mamnoor PK, Hegde P, Datla SR, Damarla RK, Rajagopalan R, Chakrabarti R.

Pharmacol Res. 2006 Aug;54(2):129-35. Epub 2006 Mar 30.

PMID:
16651004
24.

2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.

Singh SK, Vobbalareddy S, Kalleda SR, Rajjak SA, Casturi SR, Datla SR, Mamidi RN, Mullangi R, Bhamidipati R, Ramanujam R, Akella V, Yeleswarapu KR.

Org Biomol Chem. 2004 Sep 7;2(17):2442-50. Epub 2004 Aug 11.

PMID:
15326524
25.

Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.

Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R.

Eur J Pharmacol. 2004 May 3;491(2-3):195-206.

PMID:
15140637
26.

Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats.

Mamidi RN, Mullangi R, Kota J, Bhamidipati R, Khan AA, Katneni K, Datla S, Singh SK, Rao KY, Rao CS, Srinivas NR, Rajagopalan R.

Biopharm Drug Dispos. 2002 Oct;23(7):273-82.

PMID:
12355578

Supplemental Content

Support Center